BR0310033A - Inibidores da transcriptase reversa de não-nucleosìdeo - Google Patents
Inibidores da transcriptase reversa de não-nucleosìdeoInfo
- Publication number
- BR0310033A BR0310033A BR0310033-2A BR0310033A BR0310033A BR 0310033 A BR0310033 A BR 0310033A BR 0310033 A BR0310033 A BR 0310033A BR 0310033 A BR0310033 A BR 0310033A
- Authority
- BR
- Brazil
- Prior art keywords
- alkyl
- reverse transcriptase
- group
- transcriptase inhibitors
- aryl
- Prior art date
Links
- 229940042402 non-nucleoside reverse transcriptase inhibitor Drugs 0.000 title abstract 2
- 239000002726 nonnucleoside reverse transcriptase inhibitor Substances 0.000 title abstract 2
- 125000000217 alkyl group Chemical group 0.000 abstract 7
- 125000003118 aryl group Chemical group 0.000 abstract 4
- 125000000623 heterocyclic group Chemical group 0.000 abstract 4
- 229910052717 sulfur Inorganic materials 0.000 abstract 3
- 125000000753 cycloalkyl group Chemical group 0.000 abstract 2
- 125000005842 heteroatom Chemical group 0.000 abstract 2
- 229910052757 nitrogen Inorganic materials 0.000 abstract 2
- 229910052760 oxygen Inorganic materials 0.000 abstract 2
- 108010078851 HIV Reverse Transcriptase Proteins 0.000 abstract 1
- 125000003545 alkoxy group Chemical group 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 125000001188 haloalkyl group Chemical group 0.000 abstract 1
- 125000005843 halogen group Chemical group 0.000 abstract 1
- 229940002612 prodrug Drugs 0.000 abstract 1
- 239000000651 prodrug Substances 0.000 abstract 1
- 239000003419 rna directed dna polymerase inhibitor Substances 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
- 125000001424 substituent group Chemical group 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/12—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains three hetero rings
- C07D471/14—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Virology (AREA)
- Animal Behavior & Ethology (AREA)
- General Chemical & Material Sciences (AREA)
- Public Health (AREA)
- AIDS & HIV (AREA)
- Engineering & Computer Science (AREA)
- Tropical Medicine & Parasitology (AREA)
- Molecular Biology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Saccharide Compounds (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Abstract
"INIBIDORES DA TRANSCRIPTASE REVERSA DE NãO-NUCLEOSìDEO". A presente invenção refere-se a compostos representados pela fórmula (I) em que R^ 2^ é selecionado do grupo consistindo em H, (C~ 1-4~) alquila, halo, haloalquila, OH, (C~ 1-6~) alcóxi, NH(C~ 1-4~ alquila) ou N(C~ 1-4~ alquila)~ 2~; R^ 4^ é H ou Me; R^ 5^ é H ou Me; R^ 11^ é H, (C~ 1-4~) alquila, (C~ 3-4~) cicloalquila e (C~ 1-4~) alquil-(C~ 3-4~) cicloalquila; A é uma cadeia de conexão de (C~ 1-3~) alquila; B é O ou S; n é O ou 1; em que quando n for 0: o Anel C é arila de 6 ou 10 membros ou heterociclo de 5 ou 6 membros tendo de 1 a 4 heteroátomos selecionados do grupo consistindo em 0, N, e S, dita arila e dito heterociclo sendo opcionalmente substituídos; e E é CONR^ 12^R^ 13^; CONHNR^ 14^R^ 15^; NR^ 16^COR^ 17^; NR^ 18~S0~ 2~(C~ 1-6~) alquila; SO~ 2~NR^ 19^R^ 20^; OU SO~ 2~R^ 21^; ou quando n for 1: o Anel C é como definido acima e E é uma ligação simples ou um grupo de conexão; e o Anel D é arila de 6 ou 10 membros ou heterociclo de 5 ou 6 membros tendo de 1 a 4 heteroátomos selecionados do grupo consistindo em O, N, e S, a dita arila e o dito heterociclo sendo opcionalmente substituídos com de 1 a 5 substituintes; ou um sal ou uma pró-droga dos mesmos são fornecidos como inibidores da transcriptase reversa do HIV.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US38088602P | 2002-05-16 | 2002-05-16 | |
| PCT/CA2003/000718 WO2003097644A2 (en) | 2002-05-16 | 2003-05-14 | Non-nucleoside reverse transcriptase inhibitors |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BR0310033A true BR0310033A (pt) | 2005-02-15 |
Family
ID=29550032
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BR0310033-2A BR0310033A (pt) | 2002-05-16 | 2003-05-14 | Inibidores da transcriptase reversa de não-nucleosìdeo |
Country Status (28)
| Country | Link |
|---|---|
| US (1) | US6806265B2 (pt) |
| EP (1) | EP1506195B1 (pt) |
| JP (1) | JP4230448B2 (pt) |
| KR (1) | KR20050008716A (pt) |
| CN (1) | CN1318421C (pt) |
| AR (1) | AR040027A1 (pt) |
| AT (1) | ATE412653T1 (pt) |
| AU (1) | AU2003229186A1 (pt) |
| BR (1) | BR0310033A (pt) |
| CA (1) | CA2485916C (pt) |
| DE (1) | DE60324418D1 (pt) |
| EA (1) | EA009178B1 (pt) |
| EC (1) | ECSP045432A (pt) |
| ES (1) | ES2315492T3 (pt) |
| HR (1) | HRP20041065A2 (pt) |
| IL (1) | IL163753A0 (pt) |
| MX (1) | MXPA04010409A (pt) |
| MY (1) | MY134646A (pt) |
| NO (1) | NO20044104L (pt) |
| NZ (1) | NZ536736A (pt) |
| PE (1) | PE20040365A1 (pt) |
| PL (1) | PL371663A1 (pt) |
| RS (1) | RS98004A (pt) |
| TW (1) | TW200404071A (pt) |
| UA (1) | UA79285C2 (pt) |
| UY (1) | UY27809A1 (pt) |
| WO (1) | WO2003097644A2 (pt) |
| ZA (1) | ZA200406912B (pt) |
Families Citing this family (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB0302094D0 (en) | 2003-01-29 | 2003-02-26 | Pharmagene Lab Ltd | EP4 receptor antagonists |
| EP1610797A1 (en) * | 2003-03-27 | 2006-01-04 | Boehringer Ingelheim International GmbH | Antiviral combination of nevirapine and a further antiretroviral compound |
| US7348338B2 (en) | 2003-07-17 | 2008-03-25 | Plexxikon, Inc. | PPAR active compounds |
| BRPI0412684A (pt) * | 2003-07-17 | 2006-10-03 | Plexxinko Inc | compostos ppar-ativos |
| GB0324269D0 (en) | 2003-10-16 | 2003-11-19 | Pharmagene Lab Ltd | EP4 receptor antagonists |
| DE102004051277A1 (de) * | 2004-10-21 | 2006-04-27 | Merck Patent Gmbh | Heterocyclische Carbonylverbindungen |
| EP1819673A2 (en) * | 2004-11-30 | 2007-08-22 | Plexxikon, Inc. | Indole derivatives for use as ppar active compounds |
| CA2621406A1 (en) * | 2005-09-07 | 2007-03-15 | Plexxikon, Inc. | Pparactive compounds |
| CA2621474A1 (en) * | 2005-09-07 | 2007-03-15 | Plexxikon, Inc. | 1,3-disubstituted indole derivatives for use as ppar modulators |
| CA2621275A1 (en) * | 2005-09-07 | 2007-03-15 | Plexxikon, Inc. | 1 , 4 and 1 , 5-disubstituted indole derivatives for use as ppar active compounds |
| WO2008051197A2 (en) | 2005-09-20 | 2008-05-02 | Mayo Foundation For Medical Education And Research | Small-molecule botulinum toxin inhibitors |
| PE20090159A1 (es) * | 2007-03-08 | 2009-02-21 | Plexxikon Inc | COMPUESTOS DERIVADOS DE ACIDO INDOL-PROPIONICO COMO MODULADORES PPARs |
| CA2968464A1 (en) | 2014-11-25 | 2016-06-02 | Bayer Pharma Aktiengesellschaft | Substituted pyridobenzodiazepinone-derivatives and use thereof |
| KR20200030584A (ko) | 2017-07-21 | 2020-03-20 | 앤타바이오 에스에이에스 | 화합물 |
| CR20200464A (es) | 2018-03-08 | 2021-04-14 | Incyte Corp | Compuestos diólicos de aminopirazina como inhibidores de pi3k-y |
| WO2020010003A1 (en) | 2018-07-02 | 2020-01-09 | Incyte Corporation | AMINOPYRAZINE DERIVATIVES AS PI3K-γ INHIBITORS |
| CA3229569A1 (en) * | 2021-08-20 | 2023-02-23 | Enanta Pharmaceuticals, Inc. | 17-beta-hydroxysteroid dehydrogenase type 13 inhibitors and methods of use thereof |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5366972A (en) | 1989-04-20 | 1994-11-22 | Boehringer Ingelheim Pharmaceuticals, Inc. | 5,11-dihydro-6H-dipyrido(3,2-B:2',3'-E)(1,4)diazepines and their use in the prevention or treatment of HIV infection |
| US5705499A (en) * | 1995-10-06 | 1998-01-06 | Boehringer Ingelheim Pharmaceuticals, Inc. | 8-arylalkyl- and 8-arylheteroalkyl-5,11-dihydro-6H-dipyrido 3,2-B:2',3'-e! 1!diazepines and their use in the treatment of HIV-1 infection |
| TWI270547B (en) | 2000-06-16 | 2007-01-11 | Boehringer Ingelheim Ca Ltd | Non-nucleoside reverse transcriptase inhibitors |
| US6716836B2 (en) | 2001-03-22 | 2004-04-06 | Boehringer Ingelheim (Canada) Ltd. | Non-nucleoside reverse transcriptase inhibitors |
| US6673791B2 (en) | 2001-07-30 | 2004-01-06 | Boehringer Ingelheim (Canada) Ltd. | Non-nucleoside reverse transcriptase inhibitors |
-
2003
- 2003-05-06 US US10/430,116 patent/US6806265B2/en not_active Expired - Lifetime
- 2003-05-13 MY MYPI20031796A patent/MY134646A/en unknown
- 2003-05-14 CN CNB038111187A patent/CN1318421C/zh not_active Expired - Fee Related
- 2003-05-14 KR KR10-2004-7018428A patent/KR20050008716A/ko not_active Withdrawn
- 2003-05-14 BR BR0310033-2A patent/BR0310033A/pt not_active IP Right Cessation
- 2003-05-14 AT AT03724719T patent/ATE412653T1/de active
- 2003-05-14 PE PE2003000461A patent/PE20040365A1/es not_active Application Discontinuation
- 2003-05-14 JP JP2004505376A patent/JP4230448B2/ja not_active Expired - Fee Related
- 2003-05-14 CA CA002485916A patent/CA2485916C/en not_active Expired - Fee Related
- 2003-05-14 EA EA200401482A patent/EA009178B1/ru not_active IP Right Cessation
- 2003-05-14 NZ NZ536736A patent/NZ536736A/en unknown
- 2003-05-14 MX MXPA04010409A patent/MXPA04010409A/es active IP Right Grant
- 2003-05-14 ES ES03724719T patent/ES2315492T3/es not_active Expired - Lifetime
- 2003-05-14 AU AU2003229186A patent/AU2003229186A1/en not_active Abandoned
- 2003-05-14 HR HR20041065A patent/HRP20041065A2/hr not_active Application Discontinuation
- 2003-05-14 IL IL16375303A patent/IL163753A0/xx unknown
- 2003-05-14 DE DE60324418T patent/DE60324418D1/de not_active Expired - Lifetime
- 2003-05-14 RS YU98004A patent/RS98004A/sr unknown
- 2003-05-14 PL PL03371663A patent/PL371663A1/xx not_active Application Discontinuation
- 2003-05-14 EP EP03724719A patent/EP1506195B1/en not_active Expired - Lifetime
- 2003-05-14 UA UA20041210291A patent/UA79285C2/uk unknown
- 2003-05-14 WO PCT/CA2003/000718 patent/WO2003097644A2/en not_active Ceased
- 2003-05-15 UY UY27809A patent/UY27809A1/es not_active Application Discontinuation
- 2003-05-15 TW TW092113234A patent/TW200404071A/zh unknown
- 2003-05-16 AR ARP030101708A patent/AR040027A1/es unknown
-
2004
- 2004-08-31 ZA ZA200406912A patent/ZA200406912B/xx unknown
- 2004-09-27 NO NO20044104A patent/NO20044104L/no unknown
- 2004-11-16 EC EC2004005432A patent/ECSP045432A/es unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| TW200510381A (en) | Novel 2-pyridinecarboxamide derivatives | |
| BR0208985A (pt) | Derivados de 2-iminopirrolidina | |
| BRPI0514644A (pt) | composto fosforamidita, composto ácido ribonucléico, e método para produzir oligo-rna | |
| BRPI0509258A8 (pt) | composto de 8-oxoadenina 9-substituída | |
| BR0108303A (pt) | Derivados do 1h-imidazopiridina | |
| CO6140059A2 (es) | Derivados de imidazol-pirimidina para el tratamiento de enfermedades relacionadas con la glicogeno sintasa quinasa (gsk3) | |
| DE50311967D1 (de) | 3-heteroarylsubstituierte 5-methyloxymethyl-isoxazoline als herbizide | |
| BR0114436A (pt) | Composto com anel de cinco elementos contendo nitrogênio alifático | |
| DE602005023343D1 (de) | Pyrimidinderivate als gpcr-agonisten | |
| EP1679309A4 (en) | ANTISTRESS MEDICAMENT AND ITS MEDICAL USE | |
| CO5690585A2 (es) | Uso de inhibidores de la ikb-quinasa para el tratamiento del dolor | |
| BRPI0014526B8 (pt) | compostos cíclicos de seis elementos contendo nitrogênio aromático, composição farmacêutica e uso do mesmo | |
| BR9810555A (pt) | Derivados epotilona | |
| NO20052887L (no) | Pyridazinonderivater som GSK-3Beta inhibitorer. | |
| NO20051328L (no) | Kalsiumreseptormodulerende forbindelse og anvendelse derav | |
| BRPI0407810A (pt) | composto, composição farmacêutica, ativador da glicocinase, e, medicamento | |
| EP1394154A4 (en) | FIVE-GLASS HETEROCYCLIC ALKANIC ACID DERIVATIVE | |
| YU72804A (sh) | N-aril-2-oksazolidinon-5-karboksamidi i njihovi derivati i njihova primena kao antibakterijskih sredstava | |
| BRPI0406721A (pt) | Compostos condensados de furano | |
| ATE316967T1 (de) | Zyklische amidderivate die cathepsin k hemmen | |
| ECSP088805A (es) | 2-(piridin-2-il)-pirimidinas como fungicidas | |
| BRPI0406500A (pt) | processo farmacêutico e compostos preparados pelo mesmo | |
| BR0309558A (pt) | Derivados de quinazolina e medicamentos | |
| DE602005027213D1 (de) | Neue imidazolidinderivate | |
| PE20040750A1 (es) | Derivados de n-(1-acetilpiperidin-4-il)-4-benzidril-2-isopropilpiperazin-1-carboxamida como inhibidores de 17beta-hidroxiesteroide deshidrogenasa de tipo 3 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| B08F | Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette] |
Free format text: REFERENTE A 6A E 7A ANUIDADES. |
|
| B08K | Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette] |
Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 2051 DE 27/04/2010. |